PMID: 16511954Mar 4, 2006Paper

Medical management of peripheral arterial disease: a therapeutic algorithm

Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists
Alan B Lumsden, Terry W Rice

Abstract

Over half of the people with peripheral arterial disease (PAD) may be asymptomatic. The most common symptom of mild-to-moderate PAD is intermittent claudication, present in about one third of symptomatic patients. Patients with intermittent claudication often have severely impaired functional status. Despite the high prevalence of the disease and the strong association with cardiovascular morbidity and mortality, patients with PAD are less likely to receive appropriate treatment for their atherosclerotic risk factors than are those being treated for coronary artery disease. The goals of treatment are to prevent progression of systemic atherosclerosis and its associated morbidity and mortality, to prevent limb loss, and to improve functional capacity for symptomatic patients. For claudicating patients, medical management includes symptomatic treatment with cilostazol or pentoxifylline. For all patients, it is equally important to pursue risk reduction through exercise programs and promotion of smoking cessation, as well as with the use of statins, antiplatelet therapies, antithrombotic strategies, angiotensin-converting-enzyme inhibitors, beta-blockers, and attention to homocysteine levels. Because not all patients are symptomat...Continue Reading

References

Feb 6, 1992·The New England Journal of Medicine·M H CriquiD Browner
Apr 25, 1991·The New England Journal of Medicine·R ClarkeI Graham
Nov 1, 1987·Circulation·E E Ernst, A Matrai
Jan 1, 1985·Journal of the American Geriatrics Society·W B Kannel, D L McGee
Jul 1, 1985·Stroke; a Journal of Cerebral Circulation·D D SavageP A Wolf
Sep 1, 1996·Postgraduate Medical Journal·M van den Berg, G H Boers
Sep 1, 1996·The British Journal of Surgery·I C CurrieW G Tennant
Feb 19, 1998·The American Journal of Cardiology·T R PedersenT Haghfelt
Oct 10, 1998·The American Journal of Cardiology·C M Ballantyne
Jan 20, 2000·The New England Journal of Medicine·UNKNOWN Heart Outcomes Prevention Evaluation Study InvestigatorsG Dagenais
Nov 7, 2000·The American Journal of Medicine·D L DawsonD E Strandness
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Sep 19, 2001·JAMA : the Journal of the American Medical Association·A T HirschW R Hiatt
Jan 5, 2002·The New England Journal of Medicine·B G BrownJ J Albers
Dec 31, 2002·Journal of the American College of Cardiology·Michael H DavidsonEnrico P Veltri
Jun 25, 2003·Journal of the American College of Cardiology·Anho LiemDirk J van Veldhuisen
Sep 30, 2003·Journal of Vascular and Interventional Radiology : JVIR·David Sacks
Dec 20, 2003·European Heart Journal·J OstergrenUNKNOWN HOPE study investigators
May 7, 2005·PharmacoEconomics·Isabelle Durand-Zaleski, Michel Bertrand
May 12, 2005·Journal of Vascular Surgery·Thomas F RehringH Whitton Hollis

❮ Previous
Next ❯

Citations

Jul 25, 2009·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Alan B Lumsden, Tony S Das
May 13, 2014·Paediatric Anaesthesia·Mary Landrigan-Ossar, Craig D McClain

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.